The NMPA designation advances NHWD-870 HCI, an oral BET inhibitor for advanced thoracic NUT carcinoma, following Phase II data showing anti-tumour activity and survival benefit in a rare, aggressive cancer with limited treatment options. ...
The Tokyo office will support Japanese biopharmaceutical companies across the product lifecycle, combining market access, medical, marketing and strategic consulting capabilities under the leadership of Junji Yokokawa. ...
India Sebia, in collaboration with CAHO Diagnostic Division, is proud to announce the launch of the Autoimmunity Masterclass Series—a six-part academic webinar initiative aimed at advancing the understanding, early diagnosis, and clinical management of autoimmune diseases....
The redesigned website expands clinical evidence, workflow guidance and access pathways for the Vivio System, an FDA-cleared non-invasive device used to measure elevated left ventricular end-diastolic pressure in outpatient settings. ...
The NMPA acceptance of Chance Pharma’s first new drug application advances CXG87, an improved budesonide/formoterol dry powder inhalation therapy, toward potential commercialisation in China. ...
Jointly developed by SGH, SingHealth and MOHT, LEA-Net uses patient data to identify individuals at higher risk of lower extremity amputation three to five years before foot ulcers and infections develop. ...
Healthcare leaders at the Philips APAC Innovation Summit highlighted the need for stronger hospital information systems, wider digital health adoption, improved clinical workflows, and deeper collaboration across hospitals, technology providers, research bodies, and AI developers. ...
The approval allows Microsure to begin clinical use of its MUSA-3 microsurgical robotics system in Europe, while the appointment of Alex Joseph as CEO signals a shift from product development toward evidence generation, hospital adoption, and commercial execution. ...
Expansion of Vanquish procedures highlights growing adoption of minimally invasive water vapour ablation technology for prostate disease ...
National group purchasing agreement expands access to compliant pharmacy cleanroom solutions for healthcare systems ...
